Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy.
Bothiraja C, Gholap AD, Shaikh KS, Pawar AP.
Ther Deliv · journal article · DOI 10.4155/tde.14.43 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för eberconazole. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
15 hitsEfficacy and safety of terbinafine hydrochloride 1% cream vs eberconazole nitrate 1% cream in localised tinea corporis and tinea cruris.
Choudhary SV, Aghi T, Bisati S.
Indian Dermatol Online J · research-article; journal article · DOI 10.4103/2229-5178.131079Validated Stability-indicating High-performance Liquid Chromatographic Method for Estimation of Degradation Behaviour of Eberconazole Nitrate and Mometasone Furoate in Cream Formulation.
Sharma N, Rao SS, Vaghela B.
Indian J Pharm Sci · research-article; journal article · DOI 10.4103/0250-474x.113530Eberconazole--pharmacological and clinical review.
Moodahadu-Bangera LS, Martis J, Mittal R, Krishnankutty B, Kumar N, Bellary S, Varughese S, Rao PK.
Indian J Dermatol Venereol Leprol · review; journal article · DOI 10.4103/0378-6323.93651Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.
Repiso Montero T, López S, Rodríguez C, del Rio R, Badell A, Gratacós MR.
Int J Dermatol · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1365-4632.2006.02841.xEvaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture medium.
Fernández-Torres B, Inza I, Guarro J.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.49.5.2116-2118.2005Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability.
Barbanoj MJ, Antonijoan R, García-Gea C, Puntes M, Gich I, Jané F.
Methods Find Exp Clin Pharmacol · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1358/mf.2005.27.4.893581In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.
Fernández-Torres B, Inza I, Guarro J.
J Clin Microbiol · research-article; journal article · DOI 10.1128/jcm.41.11.5209-5211.2003Eberconazole (Eberconazol, Eberconazole nitrate, WAS 2160).
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-200203050-00011A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections.
del Palacio A, Ortiz FJ, Pérez A, Pazos C, Garau M, Font E.
Mycoses · clinical trial, phase iii; comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1046/j.1439-0507.2001.00632.xIn vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
Torres-Rodríguez JM, Mendez R, López-Jodra O, Morera Y, Espasa M, Jimenez T, Lagunas C.
Antimicrob Agents Chemother · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.43.5.1258[Topical treatment with eberconazole of the experimental guinea pig cutaneous candidosis.].
Torres-Rodríguez JM, Madrenys-Brunet N, Montsant L.
Rev Iberoam Micol · journal article; english abstractEberconazole. WAS 2160.
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-199901020-00012Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study.
del Palacio A, Cuétara S, Rodríguez Noriega A.
Mycoses · clinical trial, phase ii; comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1111/j.1439-0507.1995.tb00415.xInhibition of two imidazole antimycotics, eberconazole and clotrimazole, by different components of Candida albicans serotype B membrane protoplasts.
Tomás JM, Camprubí S, Merino S, Parés R, Llauradó X, Julve J.
Int J Antimicrob Agents · journal article · DOI 10.1016/0924-8579(93)90006-q